GRL-0820 (SARS-CoV-2-IN-6) is a potent and selective inhibitor of the SARS-CoV-2 3CL protease, a key viral enzyme essential for replication. This small molecule is a valuable research tool for studying coronavirus infection mechanisms and has demonstrated antiviral activity in both in vitro enzymatic assays and cellular infection models.